MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-06-0006633
Galpha Laboratories Limited. - pharma in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹302.27 Cr
▼ 7% YoY
Net loss · FY 2025
₹19.18 Cr
Net margin -6.3%
EBITDA · FY 2025
-₹6.41 Cr
EBITDA margin -2.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.99 Cr
Issued & subscribed
Open charges
₹26.97 Cr
Satisfied ₹119.57 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
954
Provident fund records
About Galpha Laboratories Limited.
Data last updated:
Galpha Laboratories Limited. is a public limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 April 1986 and has been in existence for over 40 years.
Its director Nawal Kishore Singh is #748 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR1986PLC002323. Its GSTIN is 10AABCG2175Q1ZL (Bihar). The company holds 25 GST registrations, of which 19 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.99 Cr. It was formerly known as Galpha Laboratories Private Limited. It is led by directors including Nawal Kishore Singh (Managing Director) and Jyoti Prakash Narayan Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Patna, Bihar.
As per the financials filed for FY 2025, the company reported a revenue of ₹302.27 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹19.18 Cr (net margin -6.3%) and EBITDA of -₹6.41 Cr (EBITDA margin -2.1%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years.
The company has about 954 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Galpha Laboratories. As per MCA filings, the company has open charges of ₹26.97 Cr and satisfied charges of ₹119.57 Cr on record. Court records list 212 cases involving the company, including 148 filed by the company and 64 filed against it; 48 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹4.81 Cr; the latest was in March 2017. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Gopaldas Visram and Company Limited with revenue of ₹322.71 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 691 overdue payments to 32 micro and small suppliers.
Galpha Laboratories Limited. is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0006633). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website galpha.com.
Company details
CIN U24230BR1986PLC002323
Registration Number 002323
Incorporation Date 14 April 1986
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0006633
CIN history
Galpha Laboratories Limited has one previous CIN (Corporate Identification Number): U00309BR1986PLC002323. The current CIN is U24230BR1986PLC002323, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230BR1986PLC002323 | Current |
| U00309BR1986PLC002323 | Previous |
Key People
Nawal Kishore Singh Managing Director Jyoti Prakash Narayan Singh Director Anju Singh Director Recognitions & Rankings of Galpha Laboratories Limited
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #748 Nawal Kishore Singh ₹4,200 Cr
Contact details
Galpha Laboratories Limited.'s registered office is in Patna, Bihar. Its website is galpha.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor Samprada Enclave Beside J.P Complex, Ward No. 23 Boring Road Raja Radhika Raman Path, Patna, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Galpha Laboratories Limited., buy the company report.
Comprehensive company report
Galpha Laboratories Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Galpha Laboratories Limited operates one associated brand: Galpha Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, formulations, and international exports in healthcare. | galpha.com |
Business activity
The main business activity of Galpha Laboratories Limited is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Galpha Laboratories Limited., buy the company report.
Financials of Galpha Laboratories Limited.
FY 2024 filings availableGalpha Laboratories Limited. reported revenue of ₹302.27 Cr (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹302.27 Cr ▼ 7%
Net loss · FY 2025
₹19.18 Cr margin -6.3%
EBITDA · FY 2025
-₹6.41 Cr margin -2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▼ 34%
5 years · compounded
▼ 27%
Revenue has declined at a compounded annual rate (CAGR) of 8% over three years, including a 7% fall in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.1% | ||||
| Net Profit Margin | -6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Galpha Laboratories Limited., buy the company report.
Board of directors of Galpha Laboratories Limited.
Galpha Laboratories Limited has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Prakash Narayan Singh Also directs: Man-Aash Packaging LLP, Zypheron Express LLP, Scorpion Containers Private Limited and 3 more | Director | 01 Jun 2002 | 24 Years 4 Months | Current |
| Anju Singh | Director | 15 Jun 2001 | 25 Years 4 Months | Current |
| Neha Singh Also directs: Neam Caps Private Limited | Director | 27 Sep 2010 | 16 Years 0 Months | Current |
| Khushbu Singh | Director | 27 Sep 2010 | 16 Years 0 Months | Current |
| Nawal Kishore Singh | Managing Director | 10 Mar 2015 | 11 Years 7 Months | Current |
| Rinu Sharma Also directs: Osource Global Private Limited | Director | 01 Jun 2002 | 24 Years 4 Months | Current |
Peer comparison
Galpha Laboratories Limited. is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gopaldas Visram and Company Limited | ₹322.71 Cr (FY 2025) | 15.0% | Mumabi, Maharashtra, India | |||
| Zeiss Pharma Limited | ₹310.78 Cr (FY 2025) | 13.0% | Panchkula, Haryana, India | |||
| Ultra Drugs Private Limited | ₹308.31 Cr (FY 2024) | 24.0% | Chandigarh, India | |||
| Ciron Drugs and Pharmaceuticals Private Limited | ₹304.93 Cr (FY 2024) | 15.0% | Mumbai, Maharashtra, India | |||
| Galpha Laboratories Limited.this company | ₹302.27 Cr (FY 2025) | -₹19.18 Cr | -6.3% | -7.0% | 954 | Patna, Bihar, India |
| Aagya Biotech Private Limited | ₹298.87 Cr (FY 2024) | -8.0% | Roorkee, Uttarakhand, India | |||
| Somerset Therapeutics Private Limited | ₹297.65 Cr (FY 2025) | 35.0% | Bangalore, Karnataka, India | |||
| Biomatrix Healthcare Private Limited | ₹295.64 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Globela Pharma Private Limited | ₹295.59 Cr (FY 2025) | 13.0% | Surat, Gujarat, India |
To see the full peer comparison of Galpha Laboratories Limited., buy the company report.
Auditor
Galpha Laboratories Limited. is audited by Thanu Subramanian & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Thanu Subramanian & Co | FY 2024 | 110956W |
Shareholding
The shareholding of Galpha Laboratories Limited. is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Galpha Laboratories Limited., buy the company report.
Charges & borrowings
Open charges
₹26.97 Cr
Satisfied charges
₹119.57 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2018 | 100187685 | Others | ₹25 Cr | Open | |
| 22 Nov 2013 | 10465138 | Union Bank of India | ₹50 Lakh | Open | |
| 24 Oct 2013 | 10466015 | Citi Bank N.A. | ₹1.47 Cr | Open | |
| 20 Jun 2009 | 10191434 | Union Bank of India | ₹34.61 Cr | Satisfied | |
| 02 Sep 2008 | 10125803 | The Saraswat Co-Operative Bank Ltd | ₹32.03 Cr | Satisfied |
To see the full charge records of Galpha Laboratories Limited., buy the company report.
Total charge records: 27 View all charges
Deals & funding
Galpha Laboratories Limited. has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹4.81 Cr; the latest was in March 2017.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹4.81 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Feb 2011 | Funding round | ₹4.81 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Galpha Laboratories Limited. has 212 court cases on record: 148 filed by Galpha Laboratories Limited, 64 filed against it. 48 cases are pending and 164 are disposed.
Total cases
212
Filed by the company
148
Filed against the company
64
Pending
48
Disposed
164
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 109 | 20 | 13 |
| District courts | 98 | 41 | 35 |
| Supreme Court | 4 | 3 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 212)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Arbitration matter | Filed by the company against Ang Life Sciences India Limited, | Pending |
| High Court of Rajasthan | Writ petition | Filed against the company by M/S Rajasthan Drugs and Pharmaceuticals Ltd. | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed against the company by M/S Rajasthan Drugs and Pharmaceuticals Ltd. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against Shree Ganesh Pharma and Surgical LLP and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed against the company by Torque Pharmaceuticals Pvt. Ltd. | Pending |
To see the full case history of Galpha Laboratories Limited., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Galpha Laboratories Limited. was last rated by Crisil on 30 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Jun 2020 |
To see the full credit ratings and regulatory alerts of Galpha Laboratories Limited., buy the company report.
MSME payment delays
Galpha Laboratories Limited. has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 691 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Scorpion Containers Private Limited | |||
| Kantilal Brothers | |||
| Ghanshyam Chem Industries | |||
| an individual supplier | |||
| Mahima Lifesciences Private Limited |
To see the full MSME payment records of Galpha Laboratories Limited., buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Galpha Laboratories Limited. has a workforce of 954 employees on its EPFO records as of Mar 08, 2025, across 1 active EPFO establishment.
Employee count
954
Active EPFO establishments
1
Employee growth
0.53%
GST
Galpha Laboratories Limited has 25 GST registrations: 19 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
25
Active
19
Cancelled / inactive
6
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCG2175Q1ZL | Bihar | Active | 01 Jul 2017 |
| 02AABCG2175Q1ZI | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AABCG2175Q1ZG | Punjab | Active | 01 Jul 2017 |
| 05AABCG2175Q1ZC | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Galpha Laboratories Limited., buy the company report.
Recent activity
Galpha Laboratories Limited. has 11 board changes on record since 2001: 8 appointments and 3 cessations. The latest: Kumar Saurabh ceased to be Additional Director on 30 Sep 2016.
AGM
Galpha Laboratories Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Galpha Laboratories Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna.
Charges
A charge with Others of Rs. 25.00 Cr registered on 30 May 2018 with Charge ID 100187685 was modified on 22 Dec 2023.
Charges
A charge with Citi Bank N.A. of Rs. 1.47 Cr registered on 24 Oct 2013 with Charge ID 10466015 was modified on 20 May 2019.
Charges
A charge registered on 20 Jun 2009 via Charge ID 10191434 with Union Bank Of India was fully satisfied on 01 Aug 2018.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 100187685 was registered on 30 May 2018.
Ceased
Kumar Saurabh ceased to be Additional Director.
Appointed
Kumar Saurabh was appointed as Director.
Ceased
Anand Prakash Narayan Singh ceased to be Additional Director.
Appointed
Anand Prakash Narayan Singh was appointed as Director.
Appointed
Nawal Kishore Singh was appointed as Managing Director.
Ceased
Nawal Kishore Singh ceased to be Director.
61 earlier events are in the company report.
Frequently asked questions
Galpha Laboratories Limited is an active public limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 April 1986 (40+ years old) and is registered under CIN U24230BR1986PLC002323.
Galpha Laboratories Limited has 6 current directors:
- Nawal Kishore Singh - Managing Director
- Jyoti Prakash Narayan Singh - Director
- Anju Singh - Director
- Neha Singh - Director
- Khushbu Singh - Director
- Rinu Sharma - Director
The latest financial statements of Galpha Laboratories Limited on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Galpha Laboratories Limited is 10AABCG2175Q1ZL, registered in Bihar. The company has 25 GST registrations in all, of which 19 are active and 6 are cancelled or inactive. Other active GSTINs include 02AABCG2175Q1ZI (Himachal Pradesh), 03AABCG2175Q1ZG (Punjab), 05AABCG2175Q1ZC (Uttarakhand).
The CIN (Corporate Identification Number) of Galpha Laboratories Limited is U24230BR1986PLC002323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Galpha Laboratories Limited has 212 court cases on record: 148 filed by the company and 64 filed against it. 48 are pending. Most are in the high courts.
Galpha Laboratories Limited was incorporated on 14 April 1986, making it 40+ years old. It is registered with the Registrar of Companies, Patna.
Galpha Laboratories Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹4.81 Cr; the latest was in March 2017.
The peers of Galpha Laboratories Limited by revenue are Gopaldas Visram and Company Limited, Zeiss Pharma Limited, Ultra Drugs Private Limited, Ciron Drugs and Pharmaceuticals Private Limited, Aagya Biotech Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kumar Saurabh ceased to be Additional Director on 30 Sep 2016. Kumar Saurabh was appointed as Director on 22 Mar 2016. Anand Prakash Narayan Singh ceased to be Additional Director on 08 May 2015. Galpha Laboratories Limited has 11 board changes on record in total.
Yes, Galpha Laboratories Limited is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0006633).
Galpha Laboratories Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 691 overdue payments to 32 micro and small suppliers. The latest return was filed on 30 May 2019.